- Citations, last 5 years
- 1 501
- Works, last 5 years
- 112
- h-index
- 263
- Scientists listed
- 0
- Grants since 2016
- 26
Grants received
2026–2027 · fellowship · Postdoctoral Fellowship
Investigating the Role of Protein Tyrosine Phosphatase 1B (PTP1B) inhibition in Metabolic Cardiomyopathy and HFpEF
Abhishek Kumar Mishra · Masonic Medical Research Laboratory · funded by American Heart Association
2025–2028 · research · Transformational Project Award
The pathophysiological role of VGLL4 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by American Heart Association
2024–2029 · research · R01
Molecular and morphometric imaging of coagulation and inflammation in pulmonary embolism pathogenesis
Chase William Kessinger · Masonic Medical Research Laboratory · funded by National Institutes of Health
2024–2029 · research · R01
Molecular and morphometric imaging of coagulation and inflammation in pulmonary embolism pathogenesis
Chase William Kessinger · Masonic Medical Research Laboratory · funded by National Institutes of Health
2023–2025 · research · R21
Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2023–2025 · research · R21
Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2023–2028 · research · R01
From Variants to Mechanisms for Cardiac Arrhythmias
Nathan R Tucker · Masonic Medical Research Laboratory · funded by National Institutes of Health
2022–2025 · research · R21
Mechanistic insights into polyphosphate-mediated osteoinduction.
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2022–2024 · research · R21
Mechanistic insights into polyphosphate-mediated osteoinduction.
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2021–2026 · research · R01
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by National Institutes of Health
2021–2026 · research · R01
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by National Institutes of Health
2021–2023 · training · Diversity Supplement
The in vivo function of novel PTPN11 mutations in autism and heart pathogenesis
Luana Nunes Santos · Masonic Medical Research Laboratory · funded by American Heart Association
2021–2026 · research · R01
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by National Institutes of Health
2021–2023 · research · Transformational Project Award
The role of PTPN11 mutations in autism and heart pathogenesis
Maria Kontaridis · Masonic Medical Research Laboratory · funded by American Heart Association
2021–2026 · research · R01
YAP and IRF2BP2 regulation of cardiomyocyte innate immune responses
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by National Institutes of Health
2019–2023 · research · R01
Mechanisms of Lipotoxic Arrhythmias
Ademuyiwa Aromolaran · Masonic Medical Research Laboratory · funded by National Institutes of Health
2019–2023 · research · R01
Mechanisms of Lipotoxic Arrhythmias
Ademuyiwa Aromolaran · Masonic Medical Research Laboratory · funded by National Institutes of Health
2018–2023 · career development · K01
Defining the functional variation underlying atrial fibrillation risk
Nathan R Tucker · Masonic Medical Research Laboratory · funded by National Institutes of Health
2018–2023 · career development · K01
Defining the functional variation underlying atrial fibrillation risk
Nathan R Tucker · Masonic Medical Research Laboratory · funded by National Institutes of Health
2018–2023 · career development · K01
Defining the functional variation underlying atrial fibrillation risk
Nathan R Tucker · Masonic Medical Research Laboratory · funded by National Institutes of Health
2017–2019 · research · R56
VGLL4 and IRF2BP2 regulation of cardiomyocyte survival and hypertrophy
Zhiqiang Lin · Masonic Medical Research Laboratory · funded by National Institutes of Health
2015–2020 · research · R01
Targeted inhibition of fibrosis for the prevention of heart failure
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2015–2021 · research · R01
Targeted inhibition of fibrosis for the prevention of heart failure
Jason R. Mccarthy · Masonic Medical Research Laboratory · funded by National Institutes of Health
2010–2021 · research · R01
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
Maria I Kontaridis · Masonic Medical Research Laboratory · funded by National Institutes of Health
2010–2022 · research · R01
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
Maria I Kontaridis · Masonic Medical Research Laboratory · funded by National Institutes of Health
2010–2021 · research · R01
Role of RhoA in the Molecular Pathogenesis of Heart Disease.
Maria I Kontaridis · Masonic Medical Research Laboratory · funded by National Institutes of Health
